Back to Search
JOSEPH UBERTI, MD PHD
MD PHD
Hematology & Oncology Physician
NPI: 1609813104IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301049451(MI)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
4301049451(MI)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
4301049451(MI)
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1978
Research & Publications (20)
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
PMID 16125638·Biol Blood Marrow Transplant·2005
3-trial
Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
PMID 15273705·Bone Marrow Transplant·2004
3-trial
Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
PMID 19682801·Cancer Treat Rev·2009
6-review
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.
PMID 19539211·Biol Blood Marrow Transplant·2009
3-trial
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
PMID 19539208·Biol Blood Marrow Transplant·2009
6-review
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
PMID 19344418·Br J Haematol·2009
8-other
Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.
PMID 19285626·Biol Blood Marrow Transplant·2009
6-review
Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
PMID 18721775·Biol Blood Marrow Transplant·2008
6-review
Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation.
PMID 18556719·J Oncol Pharm Pract·2008
8-other
Bronchiolitis obliterans following haematopoietic stem cell transplantation.
PMID 17470622·Eur Respir J·2007
6-review
Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
PMID 16986128·Am J Hematol·2007
3-trial
Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
PMID 16862167·Bone Marrow Transplant·2006
8-other
Do negative or positive emotions differentially impact mortality after adult stem cell transplant?
PMID 16785869·Bone Marrow Transplant·2006
6-review
Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
PMID 15093918·Int J Radiat Oncol Biol Phys·2004
3-trial
West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation.
PMID 14566328·Bone Marrow Transplant·2004
5-case
Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.
PMID 12931119·Biol Blood Marrow Transplant·2003
5-case
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
PMID 12652470·Biol Blood Marrow Transplant·2003
3-trial
Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
PMID 12171486·Biol Blood Marrow Transplant·2002
5-case
Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
PMID 11781626·Bone Marrow Transplant·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4100 JOHN R
DETROIT, MI 48201 - Phone
- (800) 527-6266
Quick Facts
- NPI
- 1609813104
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 48
- Publications
- 20
Are you this provider?
Claim Your Profile